Ontrak Inc (NASDAQ: OTRK), a virtual provider of AI-powered Telehealth solutions announced the signing of an updated contract with Health Alliance Medical Plans that extends their partnership, which originally began in 2015, to offer uninterrupted access to critical behavioral healthcare for the Medicare and commercial...
Pulmatrix Inc (NASDAQ: PULM), a Clinical Stage Biopharmaceutical Company developing inhaled therapies for the treatment of pulmonary diseases, announced the signing of a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson (NYSE: JNJ), enabling the initiative to access the Company’s...
Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease is a progressive neurodegenerative disease, characterized by the atrophy of nerve cells in brain and spinal cord, leading to hardening and scarring in the affected region. As the disease progresses, patients gradually lose the functioning of muscles,...
Paratek Pharmaceuticals (NASDAQ: PRTK), a commercial-stage biopharmaceutical Company, announced the withdrawal of its submission to the European Medicines Agency (EMA), for the grant of Marketing Authorization Application (MAA) for NUZYRA® (omadacycline). The Company was developing the candidate for two indications namely, acute bacterial skin and...
vTv Therapeutics (NASDAQ: VTVT), a clinical stage biotechnology company, presented additional positive data from a phase 2 Simplici-T1 study in patients with type 1 diabetes (T1D) at the Annual Meeting of the European Association for the Study of Diabetes in Barcelona. The clinical trial is...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive and irreversible degeneration of the lungs which is characterised by difficulty in breathing and poor airflow and manifests itself as diseases such as emphysema, chronic bronchitis and refractory (non-reversible) asthma. The World Health Organization (WHO) estimates that there...
